Test Module 2

Today Dr Tedros Adhanom Ghebreyesus, WHO Director-General, and Dr Ursula von der Leyen, President of the European Commission, co-hosted the inaugural meeting of the Access to COVID-19 Tools (ACT) Accelerator Facilitation Council.

Roles: Everyone: All Users

Regions: Canada , China, France , Italy , Norway , Rwanda , South Africa , United Kingdom , Uzbekistan

Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health

Two years into the World Health Organization’s (WHO) ambitious effort to eliminate industrially produced trans fats from the global food supply, the Organization reports that 58 countries so far have introduced laws that will protect 3.2 billion people from the harmful substance by the end of 2021. But more than 100 countries still need to take actions to remove these harmful substances from their food supplies.

Consumption of industrially produced trans fats are estimated to cause arou

Roles: Everyone: All Users

Regions: Canada , Iran , Nigeria , Turkey , United Kingdom , United States

Topics: Coronavirus (COVID-19), Energy, Global Health

The World Health Organization (WHO) has launched target product profiles to drive the rapid development of novel tuberculosis (TB) preventive treatment today. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.

One quarter of the global population is estimated to be infected with TB and are at greater risk of developing TB disease, especially those with weakened immunity. Treatment of T

Roles: Everyone: All Users

Regions: Canada , France , Italy , United Kingdom

Topics: Global Health

• Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
  
• 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor

  Roles: Everyone: All Users

  Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia

  Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• INFOSAN Quarterly Summary, 2020 #2

  During the second quarter of 2020, the INFOSAN Secretariat has been involved in 29 food safety incidents with 59 WHO Member States and two territories of WHO Member States. There were 13 biological hazard incidents (Salmonella [5], Listeria monocytogenes [3], Clostridium botulinum [2], Vibrio cholerae [1], and two involving an unspecified biological hazard), six with a chemical hazard (methanol [3], histamine [2] and patulin [1]), five involving an undeclared allergen (cashew and pistachio [1], sesame [1],

  Roles: Everyone: All Users

  Regions: Australia , Cambodia , Canada , China, Dominican Republic , France , Hong Kong , Mexico , Singapore , United States

  Topics: Combating Drugs and Crime, Coronavirus (COVID-19), Energy, Global Health

• More than 150 countries engaged in COVID-19 vaccine global access facility

  • Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)
  • The COVAX Facility, and the AMC within it, is designed to guarantee rapid, fair and equitable access to COVID-19 vaccines for every country in the world, rich and poor, to make rapid progress towards slowing the pandemic 
    
  • Interest from governments represen

    Roles: Everyone: All Users

    Regions: Argentina, Canada , Norway , United Kingdom

    Topics: Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

  • Study estimates more than one million Indians died from snakebite envenoming over past two decades

     

    India is among the countries most dramatically affected by snakebite and accounts for almost half the total number of annual deaths in the world. Authors of the article entitled ‘Trends in snakebite mortality in India from 2000 to 2019 in a nationally representative mortality study’ analysed 2,833 snakebite deaths from 611,483 verbal autopsies from an earlier study¹ and conducted a systematic lit

    Roles: Everyone: All Users

    Regions: Canada , India

    Topics: Global Health, Science, Technology, and Innovation

  • Public statement for collaboration on COVID-19 vaccine development

    Roles: Everyone: All Users

    Regions: Argentina, Canada , Chad , China, Norway , United Kingdom

    Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

  • WHO Timeline - COVID-19

    Roles: Everyone: All Users

    Regions: Canada , China, Singapore , United Kingdom

    Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

  • WHO and Global Citizen announce: 'One World: Together at home' Global Special to support healthcare workers in the fight against the COVID-19 pandemic

    Roles: Everyone: All Users

    Regions: Canada , United Kingdom

    Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

  Results 1 - 10 of 10